Dr. Susan K. Samlaska, MD

Dr. Samlaska practices at Bayfront Same Day Surgery Center, LLC. in Saint Petersburg, Florida.

Dr. Samlaska's NPI, 1548291172, was assigned on July 5, 2006. Dr. Samlaska graduated from Medical College Of Wisconsin in 1989. Dr. Samlaska holds Florida license ME76554.

Dr. Samlaska's primary practice is Bayfront Same Day Surgery Center, LLC., at 603 7th S St, Saint Petersburg, FL 33701 in Pinellas County. The practice phone is (727) 553-7906.

Dr. Samlaska's primary practice is Bayfront Same Day Surgery Center, LLC. in Saint Petersburg, Florida. The medical group on file is Emerald Coast Pain Services. Dmand AI also links Dr. Samlaska to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samlaska practices, 2 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Samlaska's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dr. Samlaska is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Samlaska's licenses on file in 7 states: Florida, Georgia, Nevada, Alabama, Arkansas, Ohio and Pennsylvania.

Dmand AI lists back pain injection, lower back pain, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Samlaska treats.

CMS data shows 368 Medicare services from Dr. Samlaska across 10 procedure codes in 2024, for 210 Medicare patients. Medicare paid $21,926 for them. Every service was in an office.

CMS counts 210 Medicare patients who saw Dr. Samlaska in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have arthritis, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Samlaska's median patient age at 67, with 55% women.

In 2024, Dr. Samlaska wrote 722 Medicare Part D claims for 266 patients. 97% of them were for generic drugs. CMS names the drug for 629 of them, across 13 drugs with 11 or more claims each, at $12,168 in total drug cost. In 2023, CMS named 407 claims across 10 drugs.

Dr. Samlaska accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Samlaska. The most frequent topics are Angiotensin-Converting Enzyme Inhibitors, Chemical Phenomena and Chemistry. Dr. Samlaska has published most often in J Antibiot (Tokyo).

CMS Open Payments shows 8 general payments to Dr. Samlaska from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Nuvectra Corporation paid the most, $44.

Dr. Samlaska graduated from Medical College Of Wisconsin in 1989.

Dr. Samlaska is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.